Chrishan Surendran Samuel

Title: Innovations of Chrishan Surendran Samuel

Introduction

Chrishan Surendran Samuel is an accomplished inventor based in Glen Waverley, Australia. He has made significant contributions to the field of experimental physiology and medicine, particularly through his innovative work at the Howard Florey Institute of Experimental Physiology and Medicine. With a total of 2 patents, Samuel's research focuses on the development of novel therapeutic approaches.

Latest Patents

Samuel's latest patents include groundbreaking work on chimeric relaxin polypeptides. These polypeptides comprise an A and B chain derived from different relaxin family peptides. The modified relaxin polypeptides feature a core amino acid sequence CGR-XXX-R-XX-I/V-XX-CG (SEQ ID NO:1), where X represents any amino acid. Additionally, he has developed a method for the treatment of anxiety, which involves human H3 preprorelaxin, human H3 prorelaxin, and human relaxin analogues. This patent describes nucleic acid sequences encoded for these relaxin forms and outlines methods for treating conditions responsive to H3 relaxin administration.

Career Highlights

Samuel's career is marked by his dedication to advancing medical science through innovative research. His work at the Howard Florey Institute has positioned him as a key figure in the exploration of relaxin's therapeutic potential. His contributions have not only expanded the understanding of relaxin but also opened new avenues for treating anxiety and related conditions.

Collaborations

Samuel has collaborated with notable colleagues, including Ross Alexander David Bathgate and John Desmond Wade. These partnerships have enriched his research and fostered a collaborative environment that encourages innovation.

Conclusion

Chrishan Surendran Samuel's work exemplifies the spirit of innovation in the field of experimental physiology and medicine. His patents reflect a commitment to developing new therapeutic strategies that can significantly impact patient care.